The LncRNA HOTAIRM1 Promotes Tamoxifen Resistance by Mediating HOXA1 Expression in ER+ Breast Cancer Cells

Breast cancer is one of the most commonly diagnosed cancers in women worldwide. Approximately 40% of patients with breast cancer acquire endocrine resistance following therapy with tamoxifen. Many explanations for the development of endocrine resistance have been put forward, one of them being the d...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Clara Yuri, Oh, Ji Hoon, Lee, Ji-Yeon, Kim, Myoung Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150441/
https://www.ncbi.nlm.nih.gov/pubmed/32284737
http://dx.doi.org/10.7150/jca.38728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150441/
https://www.ncbi.nlm.nih.gov/pubmed/32284737
http://dx.doi.org/10.7150/jca.38728

Ejemplares similares